These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 21177210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report.
    Rediti M, Pellegrini E, Molinara E, Cerullo C, Fonte C, Lunghi A, Iori A, Neri B.
    Anticancer Res; 2014 Feb; 34(2):905-7. PubMed ID: 24511030
    [Abstract] [Full Text] [Related]

  • 5. Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report.
    Hughes B, Yip D, Goldstein D, Waring P, Beshay V, Chong G.
    BMC Cancer; 2004 Oct 09; 4():74. PubMed ID: 15473910
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Imatinib mesylate in the treatment of advanced gastrointestinal stromal tumors].
    Wan DS, Wu XJ, Pan ZZ, Zhou ZW, Chen G, Li LR, Lu ZH, Ding PR.
    Zhonghua Yi Xue Za Zhi; 2006 Nov 21; 86(43):3064-7. PubMed ID: 17288838
    [Abstract] [Full Text] [Related]

  • 8. Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST).
    Gulati AP, Saif MW.
    Anticancer Res; 2012 Apr 21; 32(4):1375-7. PubMed ID: 22493373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment progress of gastrointestinal stromal tumor].
    Ji X, Ji JF.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar 21; 16(3):292-6. PubMed ID: 23536354
    [Abstract] [Full Text] [Related]

  • 11. A metastatic case of gastrointestinal stromal tumor (GIST) treated with imatinib mesylate (Glivec(®)) in Mali.
    Diallo DA, Ly M, Diallo G, Dembélé AK, Touré M, Touré BA, Koné A, Sidibé S, Dembelé M, Traore BC.
    Clin Res Hepatol Gastroenterol; 2011 Oct 21; 35(10):675-7. PubMed ID: 21641899
    [Abstract] [Full Text] [Related]

  • 12. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.
    Demetri GD.
    Semin Oncol; 2001 Oct 21; 28(5 Suppl 17):19-26. PubMed ID: 11740803
    [Abstract] [Full Text] [Related]

  • 13. [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
    Zheng S, Jia J, Pan YL, Tao DY, Lu HS.
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan 21; 42(1):42-3. PubMed ID: 23611272
    [No Abstract] [Full Text] [Related]

  • 14. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul 21; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 15. [Curative resection for bulky gastrointestinal stromal tumor with conversion therapy by imatinib].
    Nishimura T, Sakata K, Maeda Y, Nagashima Y, Okada T, Nakamura M, Setoguchi M.
    Gan To Kagaku Ryoho; 2011 Nov 21; 38(12):2202-4. PubMed ID: 22202330
    [Abstract] [Full Text] [Related]

  • 16. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B, Hornick JL, Antonescu CR, Corless CL, Fletcher CD.
    Am J Surg Pathol; 2009 Feb 21; 33(2):218-26. PubMed ID: 18830121
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The clinical characteristics and the role of surgery and imatinib treatment in patients with liver metastases from c-Kit positive gastrointestinal stromal tumors (GIST).
    Rutkowski P, Nyckowski P, Grzesiakowska U, Nowecki ZI, Nasierowska-Guttmejer A, Pienkowski A, Dudek K, Krawczyk M, Ruka W.
    Neoplasma; 2003 Feb 21; 50(6):438-42. PubMed ID: 14689066
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.